LON:YGEN Yourgene Health Share Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Yourgene Health Plc Please log in to your account or sign up in order to add this asset to your watchlist. GBX 6.75 0.00 (0.00%) (As of 06/29/2022 12:00 AM ET) Add Compare Share Today's Range 6.50▼ 6.7550-Day Range 6.68▼ 9.9552-Week Range 6.32▼ 17.30Volume127,449 shsAverage Volume1.15 million shsMarket Capitalization£48.86 millionP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileChartCompetitorsInsider TradesHeadlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive YGEN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Yourgene Health and its competitors with MarketBeat's FREE daily newsletter. Email Address YGEN Stock Forecast (MarketRank)Overall MarketRank™1.05 out of 5 starsAnalyst Opinion: 0.0Community Rank: 3.6Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.0 5 -4 -3 -2 -1 - 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for Yourgene Health. Previous Next 3.6 Community Rank Outperform VotesYourgene Health has received 17 “outperform” votes. (Add your “outperform” vote.)Underperform VotesYourgene Health has received 15 “underperform” votes. (Add your “underperform” vote.)Community SentimentYourgene Health has received 53.13% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Yourgene Health and other stocks. Vote “Outperform” if you believe YGEN will outperform the S&P 500 over the long term. Vote “Underperform” if you believe YGEN will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldYourgene Health does not currently pay a dividend.Dividend GrowthYourgene Health does not have a long track record of dividend growth. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Yourgene Health insiders have bought more of their company's stock than they have sold. Specifically, they have bought £70,000 in company stock and sold GBX 0 in company stock. Previous Next 0.0 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Yourgene Health is -4.77, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Yourgene Health is -4.77, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Growth RatioDue to a projected decrease in earnings for Yourgene Health, their PEG ratio cannot be calculated.Price to Book Value per Share RatioYourgene Health has a P/B Ratio of 1.44. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Yourgene Health (LON:YGEN)Yourgene Health Plc, a molecular diagnostic company, researches, develops, and commercializes gene analysis techniques for prenatal screening and other applications in the United Kingdom, rest of Europe, and internationally. It develops in vitro diagnostic products, such as IONA Test, a non-invasive pre-natal test (NIPT) for Down's syndrome and other genetic disorders in pregnant women; Cystic Fibrosis Screening tests; Rapid Aneuploidy Analysis, a confirmatory diagnostic test carried out after amniocentesi; and Recurrent Pregnancy Loss, a PCR assay for the routine diagnosis of the six most common chromosomes related to pregnancy loss, as well as DPYD genotyping products. The company also offers Ranger, a technology platform for sample size selection and enrichment; Elucigene DPYD assay, a PCR test to predict a patient's response to a chemotherapy treatment; and Clarigene SARS-CoV-2 CE-IVD, a PCR assay used for routine COVID-19 testing. In addition, it provides genomic services; sample preparation and analysis tools; and bioinformatics and software products. The company was formerly known as Premaitha Health PLC and changed its name to Yourgene Health Plc in November 2018. Yourgene Health Plc was incorporated in 2000 and is headquartered in Manchester, the United Kingdom.Read More YGEN Stock News HeadlinesJune 20, 2022 | finance.yahoo.comYourgene Health Launches LightBench Detect for Fetal Fraction EnrichmentJune 15, 2022 | nz.finance.yahoo.comFinteum: NatWest Group, BNY Mellon, Barclays and 11 Additional Banks Trial Intraday FX Swap and Repo Trading PlatformJune 14, 2022 | finance.yahoo.comShareholders in Yourgene Health (LON:YGEN) are in the red if they invested three years agoJune 7, 2022 | americanbankingnews.comYourgene Health (LON:YGEN) Shares Down 1.3% April 26, 2022 | marketwatch.comYourgene Health's FY 2022 Revenue Soared; Chairman to Leave Amid New Restructuring ProcessApril 15, 2022 | lse.co.ukPrimary Health Properties acquires Chiswick Medical CentreMarch 16, 2022 | finance.yahoo.comYourgene Health Plc (LON:YGEN) Shares Could Be 47% Below Their Intrinsic Value EstimateJanuary 18, 2022 | lse.co.ukYourgene Health sees FY revenue, underlying EBITDA ahead of expectationsDecember 16, 2021 | finance.yahoo.comYourgene Health (LON:YGEN) shareholders have earned a 22% CAGR over the last three yearsDecember 16, 2021 | lse.co.ukTRADING UPDATES: Cohort interim loss widens, Yourgene loss narrowsDecember 14, 2021 | marketwatch.comYourgene Gets New UK Health Security Agency ContractSeptember 16, 2021 | markets.businessinsider.comYourgene Health PLC : Re DHSC contract to support COVID-19 surge testingSeptember 10, 2021 | marketwatch.comYourgene Health Wins GBP34.1 Mln Covid-19 Testing Governmental ContractSee More Headlines Industry, Sector and Symbol Stock ExchangeLON Industry Diagnostics & Research Sub-IndustryN/A SectorMedical Current SymbolLON:YGEN CUSIPN/A CIKN/A Webwww.yourgene-health.com Phone44 16 1667 6865FaxN/AEmployees180Year FoundedN/ACompany Calendar Today6/29/2022Next Earnings (Estimated)8/09/2022Profitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E Growth-595.82Net IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity Ratio15.54 Current Ratio1.82 Quick Ratio1.34 Sales & Book Value Annual Sales£27.56 million Price / Sales1.77 Cash FlowGBX 0.62 per share Price / Cash Flow10.83 Book ValueGBX 4.70 per share Price / Book1.44Miscellaneous Outstanding Shares723,780,000Free FloatN/AMarket Cap£48.86 million OptionableNot Optionable BetaN/A Yourgene Health Frequently Asked Questions How has Yourgene Health's stock price performed in 2022? Yourgene Health's stock was trading at GBX 12.65 at the start of the year. Since then, YGEN stock has decreased by 46.6% and is now trading at GBX 6.75. View the best growth stocks for 2022 here. When is Yourgene Health's next earnings date? Yourgene Health is scheduled to release its next quarterly earnings announcement on Tuesday, August 9th 2022. View our earnings forecast for Yourgene Health. Who are Yourgene Health's key executives? Yourgene Health's management team includes the following people: Mr. Lyn Dafydd Rees, CEO & Director (Age 48, Pay $299.01k)Mr. Barry Hextall, CFO, Sec. & Exec. DirectorMr. Hayden William Jeffreys, COO & Director (Age 47, Pay $186.8k)Dr. Joanne Mason, Chief Scientific Officer & Director (Age 47, Pay $120.82k)Dr. Chia-Han Chang, Chan Ph.D., Chief Entrepreneur & Director (Age 46, Pay $151.34k)Ms. Zoe Crookes, Legal CounselMs. Joanne Cross, Director of MarketingMs. Wendy Cox, HR DirectorDr. Michael Risley, Chief Devel. OfficerDr. Matthew Forman, Head of Bioinformatics & Software Who are some of Yourgene Health's key competitors? Some companies that are related to Yourgene Health include Profound Medical (PRN), Renalytix (RENX), Profound Medical (PRN), Akumin (AKU), SQI Diagnostics (SQD), Oncimmune (ONC), Verici Dx (VRCI), VentriPoint Diagnostics (VPT), Cambridge Cognition (COG), GeneNews (GEN), LexaGene (LXG), GENinCode (GENI), genedrive (GDR), LED Medical Diagnostics (LMD) and Abingdon Health (ABDX). View all of YGEN's competitors. What other stocks do shareholders of Yourgene Health own? Based on aggregate information from My MarketBeat watchlists, some companies that other Yourgene Health investors own include L'Air Liquide (AI), Cerus (CERS), Concepta PLC (CPT.L) (CPT), Alio Gold Inc. (ALO.TO) (ALO), Alamos Gold (AGI), African Gold Group (AGG), Alpha FX Group (AFX), Aminex (AEX), Agnico Eagle Mines (AEM) and Adobe (ADBE). What is Yourgene Health's stock symbol? Yourgene Health trades on the London Stock Exchange (LON) under the ticker symbol "YGEN." How do I buy shares of Yourgene Health? Shares of YGEN and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. What is Yourgene Health's stock price today? One share of YGEN stock can currently be purchased for approximately GBX 6.75. How much money does Yourgene Health make? Yourgene Health (LON:YGEN) has a market capitalization of £48.86 million and generates £27.56 million in revenue each year. How many employees does Yourgene Health have? Yourgene Health employs 180 workers across the globe. How can I contact Yourgene Health? The official website for Yourgene Health is www.yourgene-health.com. The company can be reached via phone at 44 16 1667 6865. This page (LON:YGEN) was last updated on 6/29/2022 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. MarketBeat Resources Premium Research Tools MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools. Discover All Access Market Data and Calendars Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free. View Market Data Investing Education and Resources Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more. Financial Terms Details Here
